Perrigo Co's revenue for the
three
months ended in Sep. 2024 was €980 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €4,026 Mil.
Perrigo Co's Revenue per Share for the
three
months ended in Sep. 2024 was €7.13.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €29.41.
Warning Sign:
Perrigo Co PLC revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Perrigo Co was -6.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 4.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Perrigo Co's highest 3-Year average Revenue per Share Growth Rate was 17.50% per year. The lowest was -8.40% per year. And the median was 5.80% per year.
Perrigo Co Revenue Historical Data
The historical data trend for Perrigo Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Revenue distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Revenue falls into.
Perrigo Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4,026 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (FRA:PIG) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Perrigo Co Revenue Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PIG has been successfully added to your 